Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Clinical trial NCT06427395 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06427395
- Sponsor
- Zydus Therapeutics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-16
- Primary completion
- 2027-04-18
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.